Chapters
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
Aquadrate ® cream (10% urea) | |||
Aveeno cream | Amber - oncology use Green - paediatrics only | ||
Balneum plus ® bath additive | |||
Balneum plus cream | |||
Cavilon preparations | |||
Cetraben® emollient cream | |||
Conotrane cream | |||
Dermatonics Once Heel Balm® | Specialist recommendation for epidermolysis bullosa and diabetes patients only | ||
Dermol 500 lotion | Short term use only | ||
Dermol 600 | |||
Doublebase gel | |||
Emulsifying Ointment BP | |||
Epaderm ointment | |||
Epimax® | |||
Eucerin® intensive lotion (10% urea) | |||
Flexitol® 25% urea heak balm | Specialist recommendation | ||
Hydromol bath and shower emollient | |||
Hydromol cream | |||
Hydromol ointment | |||
Hydrous ointment BP | |||
Liquid paraffin and white soft paraffin 50:50 ointment | |||
MediHoney barrier cream | |||
Metanium ointment | |||
Paraffin yellow soft BP | CCU/ITU use | ||
ProShield | |||
ProShield Plus | |||
Sudocrem cream | |||
White soft paraffin | |||
ZeroAQS - SLS free | |||
Zerobase® | |||
Zerocream | |||
Zeroderm ointment | |||
Zeroguent® | |||
Zinc and caster oil ointment | |||
Zinc and salicylic acid paste BP (Lassar's paste) |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.